Seer (SEER) Free Cash Flow (2020 - 2026)
Seer (SEER) recorded quarterly Free Cash Flow of -$15.4 million in Q1 2026, down 42.3% quarter-over-quarter from -$10.9 million in Q4 2025, and down 34.27% on a YoY basis from -$23.5 million in Q1 2025.
Seer (SEER) Free Cash Flow (2020 - 2026) Analysis & Trends
Seer's Free Cash Flow history runs 7 years deep, the most recent figure standing at -$15.4 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 34.27% year-over-year to -$15.4 million; the TTM figure through Mar 2026 stood at -$48.5 million (down 3.37% YoY), while the FY2025 annual figure was -$44.6 million, up 3.84% from the prior year.
- Free Cash Flow was -$15.4 million for Q1 2026 at Seer, down from -$10.9 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$7.5 million in Q3 2025 to a low of -$20.2 million in Q1 2022.
- Historically, Free Cash Flow has averaged -$13.8 million across 5 years, with a median of -$14.5 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Free Cash Flow slumped 49.87% in 2022, then surged 53.83% in 2025.
- A 5-year view of Free Cash Flow shows it stood at -$9.3 million in 2022, then slipped by 29.09% to -$12.0 million in 2023, then jumped by 36.94% to -$7.6 million in 2024, then slumped by 43.09% to -$10.9 million in 2025, then tumbled by 42.3% to -$15.4 million in 2026.
- The last three Free Cash Flow figures came in at -$15.4 million (Q1 2026), -$10.9 million (Q4 2025), and -$7.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 63,220.27 |
| 10 | Seer | 95.75 Mn | 95.75 Mn | 982,000.00 | -15.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.44 Mn |
| Mar 31, 2026 | -15.44 Mn |
| Dec 31, 2025 | -10.85 Mn |
| Dec 31, 2025 | -10.85 Mn |
| Sep 30, 2025 | -7.54 Mn |
| Sep 30, 2025 | -7.54 Mn |
| Jun 30, 2025 | -14.69 Mn |
| Jun 30, 2025 | -14.69 Mn |
| Mar 31, 2025 | -11.50 Mn |
| Mar 31, 2025 | -11.50 Mn |
| Dec 31, 2024 | -7.59 Mn |
| Dec 31, 2024 | -7.59 Mn |
| Sep 30, 2024 | -16.32 Mn |
| Sep 30, 2024 | -16.32 Mn |
| Jun 30, 2024 | -11.53 Mn |
| Jun 30, 2024 | -11.53 Mn |
| Mar 31, 2024 | -10.92 Mn |
| Mar 31, 2024 | -10.92 Mn |
| Dec 31, 2023 | -12.03 Mn |
| Dec 31, 2023 | -12.03 Mn |